# A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

> **NCT02436447** · PHASE1 · COMPLETED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 23 (actual)

## Conditions studied

- Normal and Impaired Renal Function

## Interventions

- **DRUG:** MTP-131
- **DRUG:** MTP-131
- **DRUG:** MTP-131
- **DRUG:** MTP-131

## Key facts

- **NCT ID:** NCT02436447
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02436447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02436447, "A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02436447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*